Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Moxifloxacin 400 mg vs Avelox in Healthy Fasting Subjects
NCT02322619Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Nov 2012
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of moxifloxacin in bacterial infection (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area under curve. Started Nov 2012; status: completed.
02
Drugs
moxifloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02322619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322619.